Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

SpliSense is an Israel-based company focused on transformative RNA-based treatments. Our pioneering platform harnesses Antisense Oligonucleotides (ASOs) for treatment of genetic diseases such as Cystic Fibrosis. Our innovative approach targets unmet needs in genetic pulmonary diseases. SpliSense aims at targeting the root cause of the disease, to overcome specific genetic mutations and restore protein function.

List your booth number for exhibitions, ask us